Endocrine & Metabolic Disease

Endocrine and metabolic disease clinical trials requires up front strategic planning for meeting on-time patient enrollment.

 As a leading full service CRO, PSI provides the services required to support global clinical trials, offering in-depth therapeutic experience across Phase I-IV clinical programs. We provide you with the expertise that is needed to conduct your clinical trial, whether it is a Phase I study, proof-of-concept or rescuing a pivotal study where enrollment is behind schedule; our goal is to complete your study on time!

For endocrine and metabolic disease studies, where competition for patients and complexity of design are leading characteristics, we apply our years of experience and relationships with investigators to manage and support their efforts to meet enrollment goals. 

PSI has successfully performed Phase II/III studies in the following endocrine and metabolic disease indications:

PSI employs physicians as full-time monitors and project managers, most of whom are board certified specialists, including internists, gynecologists, and endocrinologists.     

Please contact PSI to learn more about our endocrine and metabolic disease therapeutic expertise that can help you achieve on-time enrollment, meeting your study goals.